Galapagos ( (GB:0JXZ) ) just unveiled an announcement.
Galapagos has received a transparency declaration and a Schedule 13D filing from Tang Capital, indicating that Tang Capital has surpassed a 5% ownership stake in Galapagos voting rights. This development reflects Tang Capital’s significant investment interest, potentially impacting Galapagos’ market position and shareholder dynamics.
More about Galapagos
Galapagos is a biotechnology company with operations in Europe and the US, dedicated to improving patient outcomes through innovative science. The company focuses on unmet medical needs and aims to enhance both the quantity and quality of life through a broad pipeline of medicines, including a decentralized cell therapy manufacturing platform.
YTD Price Performance: -8.93%
Average Trading Volume: 8,899
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: €1.58B
See more data about 0JXZ stock on TipRanks’ Stock Analysis page.